Opioid Treatment Medications Will Be Permanently More Accessible Under New Federal Rules

rredick January 25, 2023

0 Comments

Covid-19 pushed U.S. patient care to the brink. In response, take-home policies for opioid treatment medications use were temporarily relaxed. There’s evidence that these changes were massively beneficial. Now a federal agency is moving to make the changes permanent—and even expand them.

The rule change, by the Department of Health and Human Services (HHS), will make it easier to bring beneficial, sometimes life-saving, medications to people suffering from opioid use.

We’re talking about such drugs as buprenorphine (Suboxone, Sublocade), methadone, and naloxone (Narcan, Evzio). When properly used, buprenorphine and methadone can reduce cravings and dependency on opioids, providing immense help on the journey to recovery. And Naloxone, quite simply, saves lives, by rapidly reverse an opioid overdose or poisoning.

The pandemic-era rule changes allowed such medications to be more easily prescribed for home use. Despite huge challenges in accessing health care in the last several years, use of these medications has actually increased—sometimes dramatically, and with no evidence of misuse or bad outcomes.

Little wonder that the rules changes are about to become permanent. The new guidelines will also expand the number of qualified practitioners authorized to prescribe such medications.

Some good news as we round out 2022! Read the details here:

https://news.bloomberglaw.com/health-law-and-business/take-home-opioid-treatment-drug-rules-to-loosen-under-hhs-push

Tagged: Addiction Treatment, fentanyl, Medication for Addiction, Medication-Assisted Treatment (MAT/MOUD/MAUD), Methadone, Narcan, opioids, Research, Suboxone, substance use, synthetic opioids, talking about treatment, Treatment approaches

rredick

Fourth Largest Health Insurer U.S. Is Sued For Fraudulent, AI-Calculated Denial of Claims

If you’ve been thinking that concerns about artificial intelligence are overblown, this story may change your mind. But as with many abuses of new technology, human greed also plays a role.

rredick March 12, 2024

The Biden Administration Is Easing Access to Methadone

Fentanyl and other opioids are cutting lives short in numbers we’ve never seen before. Unfortunately, this health emergency hasn’t yet generated the national response we need. But there are some encouraging steps in the right direction—and among them are these new rules on access to methadone.

rredick March 5, 2024

What Happens In Recovery: A Young Man’s Journey in 2 ¼ Minutes

rredick February 27, 2024

Fentanyl Is Making “The Worst Overdose Crisis in American History” Worse All The Time

Many factors have combined to make recent years the deadliest in history for U.S. drug overdose deaths. At the same time, many policy responses, from bold to incremental, are on the negotiating table. Unfortunately, as this report from Politico explains, most of them are likely to stay there awhile. For now, in the absence of national leadership, it’s up to others to carry on.

rredick November 21, 2023

Positive Childhood Experiences Are Linked to Emotional Health and Resilience—Even in Households Experiencing Trauma

For decades, pediatric research has focused on negative childhood experiences (NCEs) and their effects on children’s wellbeing. Until recently, however, positive childhood experiences (PCEs) went mostly unstudied. Now that’s beginning to change, and the findings are encouraging to say the least.

rredick September 20, 2023

Ozempic, Widely Used for Diabetes and Weight Loss, Has Potential Substance Use Disorder Benefits As Well

It was developed to help regulate blood sugar in diabetics and pre-diabetics. It’s widely (though unofficially) used for weight loss. Now semaglutide (brand name Ozempic) is showing promise for SUD sufferers as well.

rredick September 12, 2023

Fentanyl Deaths In Communities of Color: A Crisis “Decades In the Making”

A new report from the Centers for Disease Control and Prevention reveals the unequal effects of the opioid crisis on Black, Native American, Hispanic, and white populations in the United States. Fentanyl deaths in particular have skyrocketed for all groups—but far more so in Black communities. Understanding the lasting effects of discrimination is essential, both for grasping the problem and seeking solutions.

rredick September 5, 2023

Borderline Personality Disorder: A Family Takes Its Caring to the Next Level

Borderline Personality Disorder (BPD) affects nearly 6% of Americans at some point in their lives, but research, treatment, and support for the condition lags far behind other serious mental illnesses. Paula Tusiani-Eng and her parents know first-hand what it’s like to live with, and eventually lose, a loved one suffering from BPD. Their story is remarkable not just because of those challenges, but because of what they decided to do next.

rredick August 22, 2023

Ketamine: A Potential Leap Forward In Opioid Addiction Medication

Buprenorphine is a crucial medicine for many patients in treatment for opioid use disorder (OUD). But with the rise of deadly fentanyl, buprenorphine is becoming much harder to use effectively. That’s where another medicine, ketamine, is showing immense promise.

rredick August 15, 2023

White Patients Receive Opioid Addiction Medication at More Than Twice the Rate of Black Patients

In a new report, the New England Journal of Medicine reveals that Black and Native American patients struggling with opioid use were less than half as likely to be prescribed a crucial treatment medicine as White patients. The reasons are numerous, but many stem from what the reports’ authors call “the racial segregation of healthcare” in the United States.

rredick August 2, 2023

processing...

Related Posts from "What's News"

LEAVE A COMMENT / ASK A QUESTION